>
Energy and Wealth: The Correlation That Built Nations
Cloudflare, X and Other Things Down Today
Calisthenics Are Making a Comeback as Americans Return to Bodyweight Training
World War III Unfolding Before Our Eyes
NASA announces strongest evidence yet for ancient life on Mars
Caltech has successfully demonstrated wireless energy transfer...
The TZLA Plasma Files: The Secret Health Sovereignty Tech That Uncle Trump And The CIA Tried To Bury
Nano Nuclear Enters The Asian Market
Superheat Unveils the H1: A Revolutionary Bitcoin-Mining Water Heater at CES 2026
World's most powerful hypergravity machine is 1,900X stronger than Earth
New battery idea gets lots of power out of unusual sulfur chemistry
Anti-Aging Drug Regrows Knee Cartilage in Major Breakthrough That Could End Knee Replacements
Scientists say recent advances in Quantum Entanglement...
Solid-State Batteries Are In 'Trailblazer' Mode. What's Holding Them Up?

This new method could provide a glimmer of hope for the millions of people around the world who suffer from PTSD – and that includes a much wider gamut of patients beyond military veterans who have faced combat.
Let's get a sense of what the researchers are working with here. The vagus nerve is the main nerve of your parasympathetic nervous system, which controls key involuntary body functions like your heart rate, digestion, immune system, and even your mood.
This is also the the largest parasympathetic nerve in the body, and it runs from the brain to the large intestine. There are left and right vagal nerves that join to form the vagal trunk. Stimulating these nerves with electrical impulses can help treat epilepsy and depression, and could also help address conditions like rheumatoid arthritis and PTSD.
This new treatment works in tandem with a traditional PTSD treatment called prolonged exposure therapy (PET), where patients gradually confront the memories and situations they've been struggling with, in a controlled and safe environment.
The research team, which includes scientists at The University of Texas at Dallas and Baylor University Medical Center, combined PET with the delivery of short bursts of stimulation of the vagus nerve through a small device fitted to a participant's neck.
The researchers conducted a Phase 1 trial with nine patients over 12 vagus nerve stimulation (VNS) sessions. In assessing the participants four times over the course of six months after the therapy had concluded, they found that all the patients were symptom-free.
"In a trial like this, some subjects usually do get better, but rarely do they lose their PTSD diagnosis," said Dr. Michael Kilgard, a neuroscience professor at UT Dallas and an author of the paper that appeared in the journal Brain Stimulation in March. "Typically, the majority will have this diagnosis for the rest of their lives. In this case, we had 100% loss of diagnosis. It's very promising."
VNS is thought to enhance synaptic plasticity, which refers to the brain's ability to change and adapt at the level of its neural connections. PET shows the brain what connections need to change (those involved in the fear response to trauma memories). Meanwhile, VNS provides a chemical 'boost' (through neuromodulators, or chemical messengers that can influence neural activity, like acetylcholine and norepinephrine) that makes the brain's wiring more capable of changing during that specific time.